Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study

by Rocco Totaro, Caterina Di Carmine, Gianfranco Costantino, Roberta Fantozzi, Paolo Bellantonio, Aurora Fuiani, Ciro Mundi, Stefano Ruggieri, Carmine Marini, Antonio Carolei
Published 2015-01-01

Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients

by Mario Stampanoni Bassi, Jelena Drulovic, Tatjana Pekmezovic, Ennio Iezzi, Francesco Sica, Luana Gilio, Antonietta Gentile, Alessandra Musella, Georgia Mandolesi, Roberto Furlan, Annamaria Finardi, Girolama Alessandra Marfia, Paolo Bellantonio, Roberta Fantozzi, Diego Centonze, Fabio Buttari
Published 2020-12-01

Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis

by Mario Stampanoni Bassi, Luana Gilio, Ennio Iezzi, Alessandro Moscatelli, Alessandro Moscatelli, Tatjana Pekmezovic, Jelena Drulovic, Roberto Furlan, Annamaria Finardi, Georgia Mandolesi, Georgia Mandolesi, Alessandra Musella, Alessandra Musella, Giovanni Galifi, Roberta Fantozzi, Paolo Bellantonio, Marianna Storto, Diego Centonze, Diego Centonze, Fabio Buttari
Published 2021-09-01

Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies

by Pietro Iaffaldano, Giuseppe Lucisano, Francesca Caputo, Damiano Paolicelli, Francesco Patti, Mauro Zaffaroni, Vincenzo Brescia Morra, Carlo Pozzilli, Giovanna De Luca, Matilde Inglese, Giuseppe Salemi, Giorgia Teresa Maniscalco, Eleonora Cocco, Patrizia Sola, Giacomo Lus, Antonella Conte, Maria Pia Amato, Franco Granella, Claudio Gasperini, Paolo Bellantonio, Rocco Totaro, Marco Rovaris, Marco Salvetti, Valentina Liliana Adriana Torri Clerici, Roberto Bergamaschi, Davide Maimone, Elio Scarpini, Marco Capobianco, Giancarlo Comi, Massimo Filippi, Maria Trojano
Published 2021-05-01